Gene-sequencing biotech Illumina soars on a new partnership with IBM\u2019s Watson. Analyst Simon Erickson shares why he\u2019s bullish on Illumina\u2019s future. Plus, we discuss two increasingly competitive industries: groceries and restaurants.